Related Experiment Video
Updated: Aug 16, 2026

Engineering Artificial Factors to Specifically Manipulate Alternative Splicing in Human Cells
Published on: April 26, 2017
Evidence that public database records for many cancer-associated genes reflect a splice form found in tumors and lack
Meenakshi Roy1, Qiang Xu, Christopher Lee
1Molecular Biology Institute, Center for Genomics and Proteomics, Department of Chemistry and Biochemistry, University of California Los Angeles, Los Angeles, CA 90095-1570, USA.
Abstract:
Alternative splicing is widespread in the human genome, and it appears that many genes display different splice forms in cancerous tissue than in normal human tissues. However, since cDNAs for many cancer-associated genes were originally cloned from tumor samples, it is important to ask whether this repertoire of cDNAs provides a complete or representative picture of the transcript isoforms found in normal tissues. To answer this, we used bioinformatics and RT-PCR to identify novel splice forms, focusing on in-frame exonskips, for a panel of 50 cancer-associated genes in normal tissue samples. These data show that in nearly two-thirds of the genes, normal tissues expressed previously unknown splice forms, of which 40% were normally a dominant splice form. Surprisingly, the tumor-associated splice forms were twice as likely to be represented in GenBank than their normal tissue-associated splice forms, most likely because 70% of the mRNAs in GenBank for these genes were cloned from tumor samples. As an example, we describe a novel normal splice form of IKBbeta, an important regulator of the NFkappaB pathway. Our data suggest that systematic re-evaluation of cancer genes' splice forms in normal tissue will yield insights into their distinct functions in normal tissues and in cancer. Our database contains 1308 novel normal splice forms, including many known cancer genes.
Insights
Many cancer-associated genes have previously unknown splice forms in normal tissues. Re-evaluating these normal splice forms is crucial for understanding gene function in both health and cancer.
Area of Science:
- Genomics
- Molecular Biology
- Bioinformatics
Background:
- Alternative splicing generates diverse transcript isoforms from a single gene.
- Cancer tissues often exhibit distinct splice forms compared to normal tissues.
- Existing cDNA databases may not fully represent normal tissue transcriptomes due to historical cloning biases from tumor samples.
Purpose of the Study:
- To identify novel splice forms, particularly in-frame exon skipping events, in normal human tissues for a panel of 50 cancer-associated genes.
- To assess the representation of normal versus tumor-associated splice forms in public databases.
- To provide a comprehensive database of novel normal splice forms.
Main Methods:
- Bioinformatic analysis of gene sequences.
- Reverse transcription polymerase chain reaction (RT-PCR) on normal tissue samples.
- Comparison of identified splice forms with existing databases like GenBank.
Main Results:
- Previously unknown splice forms were identified in normal tissues for nearly two-thirds of the studied cancer-associated genes.
- Approximately 40% of these novel normal splice forms were found to be the dominant splice form.
- Tumor-associated splice forms were twice as prevalent in GenBank compared to normal tissue forms, reflecting cloning biases.
- A novel normal splice form of IKBbeta, a key regulator of the NF-kappaB pathway, was identified.
- A database of 1308 novel normal splice forms was compiled.
Conclusions:
- Normal tissues harbor a significant number of previously undiscovered splice forms for cancer-associated genes.
- The current understanding of transcript isoforms in public databases is skewed towards tumor-associated forms.
- Systematic investigation of normal tissue splice forms is essential for a complete understanding of gene function in normal physiology and cancer pathogenesis.
Related Concept Videos
RNA Splicing
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancers Originate from Somatic Mutations in a Single Cell
Cancers Originate from Somatic Mutations in a Single Cell
Alternative RNA Splicing
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
